High- and low-dose cyclophosphamide in Egyptian lupus nephritis patients: a multicenter retrospective analysis.
Mohamed Momtaz A ElazizSherif M GamalAhmed FayedMohammed Hassan Abu-ZaidShada A GhoniemDoaa Ahmed TelebPublished in: Zeitschrift fur Rheumatologie (2023)
High- and low-dose CYC are comparable in early phases of treatment. However, after a longer duration of follow-up, high-dose CYC was associated with higher remission rates in the current cohort.